FAQs
Common Frequently Asked Questions
We support pharmaceutical, biotechnology, and life sciences companies at all stages—from early-stage startups to established manufacturers. Our clients often include OTC manufacturers, generic drug firms, and international companies seeking to enter or operate within the U.S. regulatory environment.
Your free consultation is a focused, 30-minute session where we assess your current quality or regulatory challenges, identify potential risks or gaps, and outline actionable next steps. Whether you’re preparing for an FDA inspection or strengthening your Quality Management System, you’ll leave with clear direction.
Yes. Vertentis provides end-to-end support for FDA inspection readiness, mock audits, and response strategies for FDA Form 483 observations and Warning Letters. We help you not only respond effectively—but also implement sustainable corrective actions.
We combine deep regulatory expertise with data-driven quality insights. Our approach emphasizes transparency, practical execution, and long-term system maturity—not just quick fixes. We don’t believe in generic solutions; every engagement is tailored to your organization’s risk profile and regulatory goals.
Getting started is simple. Book a free consultation through our website, and we’ll guide you through the next steps based on your specific needs. From there, we can structure a customized engagement—whether it’s a one-time assessment or ongoing support.